Jeremy Haigh will join in June
Jeremy Haigh will be joining the board of Proteome Sciences as CEO in June. He is a strong advocate of Precision Medicine and will bring numerous industry contacts and considerable commercial experience to the role.
Jeremy is an established leader in the biopharmaceutical sector with 30 years in clinical and operational research and development, principally at Merck and Amgen where most recently he was European Chief Operating Officer, R&D.
His basic training was in neuropharmacology and he has been significantly involved in healthcare policy and government affairs in the UK and Europe having served on the board of the BioIndustry Association (BIA), the European Federation of Pharmaceutical Industries (EFPIA) Research Directors Group, and the Association of the British Pharmaceutical Industry Innovation Board (ABPI). He is currently the Chairman of Cogent Skills Limited and a member of Imperial College Health Partners Advisory Council.